The GOG Foundation, Inc. will present Antibody Drug Conjugates as a New Class of Agents in Treating Recurrent Ovarian Cancer, an Independent Satellite Symposia during The SGO Virtual Annual Meeting on Women’s Cancer®. This session will focus on the novel therapeutic agents available and designed to target specific ovarian cancer tumor cells. The physician leadership will review the advancements in treatment options currently available. Our expert leaders will share the emerging data and outline how to integrate these treatments into clinical practice. The GOG Foundation, Inc. would like to thank its commercial supporters for Independent Medical Education Support associated with this Symposium: Mersana and Immunogen
This symposium will take place on Monday, March 22, 2021 from 6:45 pm to 8:00 pm CT.
To register and learn more about this upcoming symposium visit the Antibody Drug Conjugates as a New Class of Agents in Treating Recurrent Ovarian Cancer event page.